We are pleased to announce that PeptiDream Inc. got listed in Mothers section of the Tokyo Stock Exchange in Japan on June 11th of 2013.

The company was started up by the support of the University of Tokyo in 2006, and has a unique platform technology for the discovery of innovative macrocyclc peptides, and globally made partnerships with MegaPharms, such as Novartis and Bristol-Myers-Squibb. And develop a new class of drugs that had been difficult to discover from the traditional small molecules and antibody therapeutics.

Please see the following links for further information;

The Tokyo Stock Exchange Website
http://www.tse.or.jp/english/listing/companies/index_e.html

PeptiDream Inc Website
http://www.peptidream.com/en/